Kearney unveils Women’s Health Healthcare and Life Sciences Index
New report tracks how gender-responsive practices that improve the health of women are embedded across pharma, MedTech, consumer health, payor, provider, and investor value chains.
New report tracks how gender-responsive practices that improve the health of women are embedded across pharma, MedTech, consumer health, payor, provider, and investor value chains.
$34 billion in private capital investments have not been aligned with disease burden priorities.